comparemela.com

Latest Breaking News On - Medivir - Page 1 : comparemela.com

MEDIVIR AB - INTERIM REPORT JANUARY

/PRNewswire/ Preparations for the planned phase 2b study continue according to plan after the completed Type C meeting with the FDA, strengthened by the.

Champagne ardenneSan franciscoUnited statesMagnus christensenAnders hallbergJens lindbergStefan bengtssonJanuary tango therapeuticsHallberg managementHealthinvest partnersRare pediatric disease designationOrphan drug designationInterim report januaryObjective response rateTango therapeuticsPerthes disease

FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease

/PRNewswire/ Medivir AB (NASDAQ: MVIR) (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

United statesMagnus christensenRare pediatric disease designationOrphan drug designationPerthes diseasePriority review voucherNasdaq stockholmSmall cap

Medivir 2023 Annual Report published

/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report for 2023 now is available at the company s website: www.medivir.com..

Magnus christensenNasdaq stockholmAnnual reportSmall cap

Medivir presents data that strengthens the fostrox/Lenvima combination in primary liver cancer at EASL Liver Cancer Summit

/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet.

Pia baumannMagnus christensenNasdaq stockholmEuropean associationLiver cancer summitKarin tunblad phdProject directorChief medical officerSmall capEuropean journalHealth care amp hospitalsMedical pharmaceuticalsClinical trials amp medical discoveries

MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2023

/PRNewswire/ "The clinical efficacy of fostrox in combination with Lenvima continues to improve with median time to progression having increased to over 6.

San franciscoUnited statesJens lindbergAnette lindqvistKarl tobiesonUli hacksellAnders hallbergRichard torgersonMagnus christensenAsco gi congress onNomination committeeBoard memberNordea investment fundsHealthinvest partnersHallberg managementJanuary tango therapeutics

vimarsana © 2020. All Rights Reserved.